Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
P1.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 116
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.04-076 - CDCA3 Is a Novel Cell Cycle Regulator in Lung Cancer
09:30 - 09:30 | Author(s): M.N. Adams
- Abstract
Loading... -
+
P1.04-088 - Lung Cancer Cells Can Alter the Behaviour of Normal Bronchial Epithelial Cells Through Multiple Mechanisms
09:30 - 09:30 | Author(s): A. Baird
- Abstract
Loading... -
+
P1.04-105 - The Development and Assessment of Advanced Cellular Models for the Study of Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S. Ryan
- Abstract
Loading...
-
+
P1.08 - Poster Session/ Thymoma, Mesothelioma and Other Thoracic Malignancies
- Type: Poster
- Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
- Presentations: 39
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.08-014 - The Small Molecule Inhibitor, LCRF004, Is Effective in Targeting the RON/MST1R Pathway in Malignant Pleural Mesothelioma
09:30 - 09:30 | Author(s): A. Baird
- Abstract
Loading...
-
+
MINI 05 - EGFR Mutant Lung Cancer 1
- Type: Mini Oral
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 14
- Moderators:Y. Yatabe
- Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 2a-3b
-
+
MINI05.08 - Comparison of the Efficacy of Dacomitinib v Erlotinib for NSCLC Pts with Del 19/L858R
17:25 - 17:30 | Author(s): S.S. Ramalingam
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 08 - Prognostic/Predictive Biomarkers
- Type: Mini Oral
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 15
- Moderators:T.E. Stinchcombe
- Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 4a-4f
-
+
MINI08.08 - VEGF-Mediated Cell Survival in NSCLC: Implications for Epigenetic Targeting of VEGF Receptors as a Therapeutic Approach
17:35 - 17:40 | Author(s): M.P. Barr
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MINI08.10 - Co-Occurrence of Driver Mutations of MAPK and PI3K Pathways in Non Small Cell Lung Cancer: A Report from Lung Cancer Genomics Ireland (LCGI) Study
17:45 - 17:50 | Author(s): S. Rafee
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
HOD 02 - Highlights of the Previous Day: Biology, Pathology, Molecular Testing, Prevention, Tobacco Control, Screening and Early Detection
- Type: Highlights of the Day
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 3
- Coordinates: 9/08/2015, 07:00 - 08:00, Four Seasons Ballroom F3+F4
-
+
HOD02.01 - Biology, Pathology, Molecular Testing
07:00 - 07:20 | Author(s): K.J. O'Byrne
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 109
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.04-057 - Targeting PIM Kinase in NSCLC
09:30 - 09:30 | Author(s): K. Gately
- Abstract
Loading... -
+
P2.04-099 - Differential Regulation of DNA Repair Genes in Cisplatin Resistant Non-Small Cell Lung Cancer Cells
09:30 - 09:30 | Author(s): Y. He
- Abstract
Loading... -
+
P2.04-102 - Targeting Inflammatory Mediators to Overcome Intrinsic and Acquired Cisplatin Resistance in Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): A. Baird
- Abstract
Loading... -
+
P2.04-109 - Epithelial-To-Mesenchymal Transition (EMT) and Acquired Resistance to PI3K-mTOR Inhibition in NSCLC
09:30 - 09:30 | Author(s): K. Gately
- Abstract
Loading...
-
+
P2.08 - Poster Session/ Thymoma, Mesothelioma and Other Thoracic Malignancies
- Type: Poster
- Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
- Presentations: 35
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.08-006 - The JmjC Family of Lysine Demethylases Are Overexpressed and Potential Therapeutic Targets in Malignant Pleural Mesothelioma
09:30 - 09:30 | Author(s): M. Breslin
- Abstract
Loading...
-
+
MINI 13 - Genetic Alterations and Testing
- Type: Mini Oral
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 15
- Moderators:Y. Koh
- Coordinates: 9/08/2015, 10:45 - 12:15, 205+207
-
+
MINI13.08 - Targetable Genomic Aberrations in Squamous Cell Lung Cancer (SCC): A Report from the Lung Cancer Genomics Ireland (LCGI) Study
11:25 - 11:30 | Author(s): S. Rafee
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.08 - Poster Session/ Thymoma, Mesothelioma and Other Thoracic Malignancies
- Type: Poster
- Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
- Presentations: 38
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.08-008 - Tip60 (KAT5) May Be a Candidate for Therapeutic Targeting in Malignant Pleural Mesothelioma
09:30 - 09:30 | Author(s): S. Cregan
- Abstract
Loading...
-
+
ORAL 32 - EGFR WT and MT Targeting
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 8
- Moderators:K.J. O'Byrne
- Coordinates: 9/09/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
-
+
ORAL32.01 - Tumor Genomic Analysis from LUX-Lung 8: A Phase III Trial of Afatinib versus Erlotinib in Squamous Cell Carcinoma of the Lung
16:45 - 16:56 | Author(s): J. Soria
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ORAL32.02 - Long-Term Survivors with EGFR Wild-Type Advanced NSCLC Treated with Second-Line Erlotinib: Subgroup Analysis from WILT Study
16:56 - 17:07 | Author(s): J. De Castro
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ORAL32.03 - Efficacy and Safety of Necitumumab Continuation Therapy in Phase 3 SQUIRE Study
17:07 - 17:18 | Author(s): T. Ciuleanu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ORAL32.04 - Discussant for ORAL32.01, ORAL32.02, ORAL32.03
17:18 - 17:28 | Author(s): Y. Wu
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ORAL32.05 - EGFR IHC and FISH Correlative Analyses (SQUIRE Trial): Necitumumab + Gemcitabine-Cisplatin vs Gemcitabine-Cisplatin in 1st-Line Squamous NSCLC
17:28 - 17:39 | Author(s): F.R. Hirsch
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ORAL32.06 - Intercalating and Maintenance Use of Gefitinib plus Chemotherapy versus Chemotherapy Alone in Selected Advanced NSCLC: A Phase III Study
17:39 - 17:50 | Author(s): H. Jian
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ORAL32.07 - Randomized Phase II Trial of Sequential Gefitinib and Pemetrexed/Cisplatin Chemotherapy for Stage IIIB/IV Lung Adenocarcinoma in Never Smokers
17:50 - 18:01 | Author(s): J.S. Lee
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ORAL32.08 - Discussant for ORAL32.05, ORAL32.06, ORAL32.07
18:01 - 18:11 | Author(s): D.R. Gandara
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.